AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Capillary Leak Syndrome
AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Capillary Leak Syndrome
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75947a-eng.php
AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Capillary Leak Syndrome
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75947a-eng.php
Coronavirus (COVID-19) Update: June 25, 2021
http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-june-25-2021
Eventos post vacunación contra COVID-19 son reportados en solo el 0,3% de la población inmunizada Dolor de cabeza continúa siendo el evento más reportado
25 de junio del 2021. Solamente el 0,3% de la población vacunada contra la COVID-19 al 31 de mayo...
Medtronic Heartware Ventricular Assist Device System – Recall Due to Risk of Neurological Adverse Events, Mortality and Delay or Failure to Restart
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75905a-eng.php
Coronavirus (COVID-19) Update: FDA Authorizes Drug for Treatment of COVID-19
http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-drug-treatment-covid-19
FDA In Brief: FDA Encourages Inclusion of Patients with Incurable Cancers in Oncology Clinical Trials Regardless of Prior Therapies
http://www.fda.gov/news-events/press-announcements/fda-brief-fda-encourages-inclusion-patients-incurable-cancers-oncology-clinical-trials-regardless